EMGRAF
Main information
- Trade name:
- EMGRAF 10 CAP
- Active ingredient:
- TACROLIMUS
- Available from:
- Emcure
- Dosage:
- 2MG
- Pharmaceutical form:
- CAP
- Composition:
- 10
- Medicine domain:
- Humans
- Medicine type:
- Allopathic drug
Documents
- for the general public:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- for healthcare professionals:
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for healthcare professionals.
Localization
- Available in:
-
India
- Language:
- English
Other information
Status
- Source:
- Central Drugs Standard Control Organization
- Last update:
- 09-08-2016
- The information leaflet for this product is not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain it.
Request the information leaflet for the general public.
- Access to this document is only available to registered users.
Register now for full access
30-1-2018
Human medicines European public assessment report (EPAR): Protopic, tacrolimus, Revision: 22, Authorised
Europe - EMA - European Medicines Agency
29-1-2018
Human medicines European public assessment report (EPAR): Advagraf, tacrolimus, Revision: 16, Authorised
Europe - EMA - European Medicines Agency
26-1-2018
Human medicines European public assessment report (EPAR): Tacforius, tacrolimus, Revision: 0, Authorised
Europe - EMA - European Medicines Agency
16-11-2017
Human medicines European public assessment report (EPAR): Modigraf, tacrolimus, Revision: 10, Authorised
Europe - EMA - European Medicines Agency
17-10-2017
Orphan designation: Tacrolimus, for the: Treatment of pulmonary arterial hypertension
Europe - EMA - European Medicines Agency
13-10-2017
Pending EC decision: Tacforius, tacrolimus, Opinion date: 12-Oct-2017
Europe - EMA - European Medicines Agency
30-5-2017
Human medicines European public assessment report (EPAR): Envarsus, tacrolimus, Revision: 5, Authorised
Europe - EMA - European Medicines Agency
7-3-2018
![TACROLIMUS MONOHYDRATE (Tacrolumus Monohydrate) Powder [Attix Pharmaceuticals Inc]](/web/assets/global/img/flags/us.png)
TACROLIMUS MONOHYDRATE (Tacrolumus Monohydrate) Powder [Attix Pharmaceuticals Inc]
Updated Date: Mar 7, 2018 EST
US - DailyMed
12-2-2018
ENVARSUS XR (Tacrolimus) Tablet, Extended Release [Carton Service, Incorporated]
Updated Date: Feb 12, 2018 EST
US - DailyMed
31-1-2018
TACROLIMUS Capsule [A-S Medication Solutions]
Updated Date: Jan 31, 2018 EST
US - DailyMed
23-1-2018
TACROLIMUS Capsule [Mylan Pharmaceuticals Inc.]
Updated Date: Jan 23, 2018 EST
US - DailyMed
16-1-2018
PROTOPIC (Tacrolimus) Ointment [LEO Pharma Inc.]
Updated Date: Jan 16, 2018 EST
US - DailyMed
19-12-2017
AX PHARMACEUTICAL CORP (Tacrolimus) Powder [AX Pharmaceutical Corp]
Updated Date: Dec 19, 2017 EST
US - DailyMed
12-12-2017
Tacforius (Teva B.V.)
Tacforius (Active substance: tacrolimus) - Centralised - Authorisation - Commission Decision (2017)8596 of Tue, 12 Dec 2017 European Medicines Agency (EMA) procedure number: EMEA/H/C/4435
Europe -DG Health and Food Safety
1-12-2017
TACROLIMUS Capsule [American Health Packaging]
Updated Date: Dec 1, 2017 EST
US - DailyMed
16-11-2017
TACROLIMUS Capsule [Golden State Medical Supply, Inc.]
Updated Date: Nov 16, 2017 EST
US - DailyMed
31-10-2017
TACROLIMUS Ointment [E. Fougera Co. A Division Of Fougera Pharmaceuticals Inc.]
Updated Date: Oct 31, 2017 EST
US - DailyMed
26-10-2017
TACROLIMUS Capsule [Aphena Pharma Solutions - Tennessee, LLC]
Updated Date: Oct 26, 2017 EST
US - DailyMed
19-10-2017
ENVARSUS XR (Tacrolimus) Tablet, Extended Release [Veloxis Pharmaceuticals, Inc]
Updated Date: Oct 19, 2017 EST
US - DailyMed
25-8-2017
EU/3/17/1912 (VIVUS B.V.)
EU/3/17/1912 (Active substance: Tacrolimus) - Orphan designation - Commission Decision (2017)5921 of Fri, 25 Aug 2017 European Medicines Agency (EMA) procedure number: EMA/OD/099/17
Europe -DG Health and Food Safety
19-7-2017
X (Tacrolimus) Powder [AX Pharmaceutical Corp]
Updated Date: Jul 19, 2017 EST
US - DailyMed
13-7-2017
TACROLIMUS Capsule, Gelatin Coated [Panacea Biotec Ltd]
Updated Date: Jul 13, 2017 EST
US - DailyMed
11-7-2017
PROGRAF (Tacrolimus) Capsule, Gelatin Coated PROGRAF (Tacrolimus) Injection, Solution [Astellas Pharma US, Inc.]
Updated Date: Jul 11, 2017 EST
US - DailyMed